Express Diagnostics Representatives to Speak at End Violence Against Women International’s 2014 Conference
Blue Earth, Minn. (PRWEB) April 16, 2014 -- Express Diagnostics Int’l, Inc. (EDI) is pleased to announce that representatives from the company will be speaking next week at the 2014 conference of End Violence Against Women International (EVAWI), April 22-24 in Seattle, Wash. Express Diagnostics is also a corporate sponsor for the conference.
“Express Diagnostics is honored to be supporting EVAWI’s conference and their mission,” says Rich Strasser, COO of Express Diagnostics. “As a retired detective from California, I have seen the tragic results of some of the horrific crimes committed against women and I applaud the efforts of Joanne Archambault and everyone at EVAWI for their relentless efforts to train and educate the law enforcement community.”
Strasser and Les Wilson, director of technical resources at EDI, will present “Characteristics of Drugs Used in Drug-Facilitated Sexual Assaults.” The presentation will provide information on the biological effects of substances typically used in drug-facilitated sexual assaults, such as ecstasy, gamma-hydroxybutyric acid (GHB), ketamine, and rohypnol. Strasser and Wilson will also discuss rapid drug-screening devices available to law enforcement that can provide valuable, immediate information in the early stages of a sexual assault investigation.
EVAWI’s vision statement summarizes the goal of the annual conference: “We envision a world where gender-based violence is unacceptable; where perpetrators are held accountable, and victims receive the compassion, support, and justice they deserve.” The three-day conference, titled “International Conference on Sexual Assault, Domestic Violence and Trafficking,” will highlight emerging issues and promising practices that can be implemented by law enforcement personnel, prosecutors, victim advocates, judges, rape crisis workers, and medical personnel.
This year’s sponsorship and presentation marks EDI’s first time participating in the End Violence Against Women International conference. “EVAWI is pleased to welcome Express Diagnostics to present different drug screening technologies available in the investigation of drug-facilitated sexual assaults,” says Joanne Archambault, executive director of EVAWI. “Our largest contingent of conference participants comes from the law enforcement community and this is a great opportunity to get these technologies out to them so they know what tools are available.”
For more details and a full conference agenda, visit evawintl.org.
About Express Diagnostics Int’l, Inc.
Express Diagnostics Int’l manufactures and distributes DrugCheck® onsite urine and saliva screening devices for the detection of drugs of abuse, as well as a growing catalog of rapid alcohol screening and health diagnostic devices. With accuracy comparable to laboratory testing, Express Diagnostics onsite devices provide a variety of industries fast, cost-effective alternatives to higher-priced lab services. Learn more at drugcheck.com.
Beth Moss, Express Diagnostics, http://www.drugcheck.com, 507-526-3951 Ext: 4870, [email protected]
Share this article